FGFR3 alterations in bladder cancer: Sensitivity and resistance to targeted therapies.
Noeraparast M, Krajina K, Pichler R, Niedersüß-Beke D, Shariat SF, Grünwald V, Ahyai S, Pichler M. Cancer Commun (Lond). 2024 Oct;44(10):1189-1208. doi: 10.1002/cac2.12602. Epub 2024 Aug 19. PMID: 39161208
Enhancing oncogenic signaling to kill cancer cells.
Noeparast M, Timofeev O, Pichler M. Trends Pharmacol Sci. 2024 Jun;45(6):475-477. doi: 10.1016/j.tips.2024.04.011. Epub 2024 May 10. PMID: 38734500
Nivolumab + Ipilimumab as Immunotherapeutic Boost in Metastatic Urothelial Carcinoma: A Nonrandomized Clinical Trial.
Grimm MO, Schostak M, Grün CB, Loidl W, Pichler M, Zimmermann U, Schmitz-Dräger B, Steiner T, Roghmann F, Niegisch G, Bolenz C, Schmitz M, Baretton G, Leucht K, Schumacher U, Foller S, Zengerling F, Meran J; TITAN-TCC Study Group. JAMA Oncol. 2024 Jun 1;10(6):755-764. doi: 10.1001/jamaoncol.2024.0938. PMID: 38722641 Clinical Trial.
ERK pathway agonism for cancer therapy: evidence, insights, and a target discovery framework.
Timofeev O, Giron P, Lawo S, Pichler M, Noeparast M. NPJ Precis Oncol. 2024 Mar 14;8(1):70. doi: 10.1038/s41698-024-00554-5. PMID: 38485987
Detection of Recurrence through microRNA-371a-3p Serum Levels in a Follow-up of Stage I Testicular Germ Cell Tumors in the DRKS-00019223 Study.
Belge G, Dumlupinar C, Nestler T, Klemke M, Törzsök P, Trenti E, Pichler R, Loidl W, Che Y, Hiester A, Matthies C, Pichler M, Paffenholz P, Kluth L, Wenzel M, Sommer J, Heinzelbecker J, Schriefer P, Winter A, Zengerling F, Kramer MW, Lengert M, Frey J, Heidenreich A, Wülfing C, Radtke A, Dieckmann KP. Clin Cancer Res. 2024 Jan 17;30(2):404-412. doi: 10.1158/1078-0432.CCR-23-0730. PMID: 37967143
MiR-4649-5p acts as a tumor-suppressive microRNA in triple negative breast cancer by direct interaction with PIP5K1C, thereby potentiating growth-inhibitory effects of the AKT inhibitor capivasertib.
Jonas K, Prinz F, Ferracin M, Krajina K, Pasculli B, Deutsch A, Madl T, Rinner B, Slaby O, Klec C, Pichler M. Breast Cancer Res. 2023 Oct 6;25(1):119. doi: 10.1186/s13058-023-01716-2. PMID: 37803350
MicroRNA mimics can distort physiological microRNA effects on immune checkpoints by triggering an antiviral interferon response.
Prinz F, Jonas K, Balihodzic A, Klec C, Reicher A, Barth DA, Riedl J, Gerger A, Kiesslich T, Mayr C, Rinner B, Kargl J, Pichler M. RNA Biol. 2022 Jan;19(1):1305-1315. doi: 10.1080/15476286.2022.2152978. PMID: 36469564
Improved overall survival of metastatic renal cell carcinoma patients in the era of modern tyrosine kinase inhibitors and immune checkpoint inhibitors: results from a real-life, population-based Austrian study comprising three decades of follow-up.
Fluhrer H, Hutterer GC, Golbeck S, Stidl M, Niedrist T, Pichler R, Mischinger J, Seles M, Mannweiler S, Spiegelberg J, Bauernhofer T, Jost PJ, Ahyai S, Zigeuner R, Pichler M, Barth DA. Ther Adv Med Oncol. 2022 Nov 19;14:17588359221134065. doi: 10.1177/17588359221134065. eCollection 2022. PMID: 36425872
ALYREF, a novel factor involved in breast carcinogenesis, acts through transcriptional and post-transcriptional mechanisms selectively regulating the short NEAT1 isoform.
Klec C, Knutsen E, Schwarzenbacher D, Jonas K, Pasculli B, Heitzer E, Rinner B, Krajina K, Prinz F, Gottschalk B, Ulz P, Deutsch A, Prokesch A, Jahn SW, Lellahi SM, Perander M, Barbano R, Graier WF, Parrella P, Calin GA, Pichler M. Cell Mol Life Sci. 2022 Jul 1;79(7):391. doi: 10.1007/s00018-022-04402-2. PMID: 35776213
Non-coding RNAs and ferroptosis: potential implications for cancer therapy.
Balihodzic A, Prinz F, Dengler MA, Calin GA, Jost PJ, Pichler M. Cell Death Differ. 2022 Jun;29(6):1094-1106. doi: 10.1038/s41418-022-00998-x. Epub 2022 Apr 14. PMID: 35422492
Trends and Patterns in the Public Awareness of Palliative Care, Euthanasia, and End-of-Life Decisions in 3 Central European Countries Using Big Data Analysis From Google: Retrospective Analysis.
Huemer M, Jahn-Kuch D, Hofmann G, Andritsch E, Farkas C, Schaupp W, Masel EK, Jost PJ, Pichler M. J Med Internet Res. 2021 Sep 20;23(9):e28635. doi: 10.2196/28635. PMID: 34542419
Vollständige Publikationsliste Prof. Dr. Martin Pichler
